Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of July 21, 2026, CHE trades at $501.80 with a market cap of $6.82B and a P/E ratio of 27.24. CHE moved -1.86% today. Year to date, CHE is +19.23%; over the trailing twelve months it is +13.82%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $473.00. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CHE news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $501.80 |
| Market Cap | $6.82B |
| P/E Ratio | 27.24 |
| EPS | $18.36 |
| Dividend Yield | 0.60% |
| 52-Week High | $623.61 |
| 52-Week Low | $365.21 |
| Volume | 233.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.54B |
| Net Income | $259.78M |
| Gross Margin | 32.38% |
2 analysts cover CHE: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $473.00.